Trial Profile
Pharmacokinetics of intravenous Cremophor-containing tanespimycin and tanespimycin suspension in patients with solid tumours
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jul 2011
Price :
$35
*
At a glance
- Drugs Tanespimycin (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 05 Nov 2010 New trial record.